Angiotensin A/Alamandine/MrgD axis: Another clue to understanding cardiovascular pathophysiology

International Journal of Molecular Sciences

Volumn 17, Issue 7, 2016, Pages

  Hrenak, Jaroslav ^a,b   Paulis, Ludovit ^a,c   Simko, Fedor ^a,d  

^a Bratislava   (Slovakia)

^b Donauisar Klinikum   (Germany)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Alamandine; Angiotensin A; MrgD receptor; Renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; 3 AMINO 2 METHYLPROPIONIC ACID; ALAMANDINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN A; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DIETHYLSTILBESTROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; MAS RELATED G PROTEIN COUPLED RECEPTOR D; UNCLASSIFIED DRUG; MRGD PROTEIN, HUMAN; OLIGOPEPTIDE;

AMINO ACID SEQUENCE; ATHEROGENIC DIET; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; DRUG MECHANISM; ESSENTIAL HYPERTENSION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MASS SPECTROMETRY; NERVE EXCITABILITY; NONHUMAN; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ROSTRAL VENTROLATERAL MEDULLA; VASODILATATION; METABOLISM;

ANGIOTENSINS; CARDIOVASCULAR DISEASES; HUMANS; OLIGOPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84979084867     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17071098     Document Type: Review

References (39)

1. Paulis, L.; Rajkovicova, R.; Simko, F. New developments in the pharmacological treatment of hypertension: Dead-end or a glimmer at the horizon? Curr. Hypertens. Rep. 2015, 17, 557
2. Unger, T.; Paulis, L.; Sica, D.A. Therapeutic perspectives in hypertension: Novel means for renin-angiotensinaldosterone system modulation and emerging device-based approaches. Eur. Heart J. 2011, 32, 2739-2747
3. Simko, F.; Pechanova, O.; Repova Bednarova, K.; Krajcirovicova, K.; Celec, P.; Kamodyova, N.; Zorad, S.; Kucharska, J.; Gvozdjakova, A.; Adamcova, M.; et al. Hypertension and cardiovascular remodelling in rats exposed to continuous light: Protection by ACE-inhibition and melatonin. Mediators Inflamm. 2014
4. Simko, F.; Simko, J.; Fabryova, M. ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: Pathophysiological consideration of the unresolved battle. Cardiovasc. Drugs Ther. 2003, 17, 287-290
5. Simko, F.; Pechanova, O.; Pelouch, V.; Krajcirovicova, K.; Mullerova, M.; Bednarova, K.; Adamcova, M.; Paulis, L. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. J. Hypertens. Suppl. 2009, 27, S5-S10
6. Hrenák, J.; Arendášová, K.; Rajkovičová, R.; Aziriová, S.; Repová, K.; Krajčírovičová, K.; Celec, P.; Kamodyová, N.; Bárta, A.; Adamcová, M.; et al. Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats. Physiol. Res. 2013, 62, S181-S189.
7. Paulis, L.; Foulquier, S.; Namsolleck, P.; Recarti, C.; Steckelings, U.M.; Unger, T. Combined angiotensin receptor modulation in the management of cardio-metabolic disorders. Drugs 2016, 76, 1-12
8. Aziriova, S.; Repova Bednarova, K.; Krajcirovicova, K.; Hrenak, J.; Rajkovicova, R.; Arendasova, K.; Kamodyova, N.; Celec, P.; Zorad, S.; Adamcova, M.; et al. Doxorubicin-induced behavioral disturbances in rats: Protective effect of melatonin and captopril. Pharmacol. Biochem. Behav. 2014, 124, 284-289
9. Simko, F.; Pechanova, O.; Krajcirovicova, K.; Matuskova, J.; Pelouch, V.; Adamcova, M.; Paulis, L. Effects of captopril, spironolactone, and simvastatin on the cardiovascular system of non-diseased Wistar rats. Int. J. Cardiol. 2015, 190, 128-130
10. Danyel, L.A.; Schmerler, P.; Paulis, L.; Unger, T.; Steckelings, U.M. Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure. Integr. Blood Press. Control 2013, 6, 153-161
11. Hrenak, J.; Paulis, L.; Simko, F. N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain. Curr. Pharm. Des. 2015, 21, 5135-5143
12. Dzau, V.J. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Basic Res. Cardiol. 1993, 88, 1-14
13. Steckelings, U.M.; Paulis, L.; Unger, T.; Bader, M. Emerging drugs which target the renin-angiotensin-aldosterone system. Expert Opin. Emerg. Drugs 2011, 16, 619-630
14. Simko, F.; Simko, J. Heart failure and angiotensin converting enzyme inhibition: Problems and perspectives. Physiol. Res. 1999, 48, 1-8
15. Lv, L.L.; Liu, B.C. Role of non-classical renin-angiotensin system axis in renal fibrosis. Front. Physiol. 2015, 6, 117
16. Villela, D.; Leonhardt, J.; Patel, N.; Joseph, J.; Kirsch, S.; Hallberg, A.; Unger, T.; Bader, M.; Santos, R.A.; Sumners, C.; et al. Angiotensin type 2 receptor (AT2R) and receptor Mas: A complex liaison. Clin. Sci. 2015, 128, 227-234
17. Jankowski, V.; Vanholder, R.; van der Giet, M.; Tölle, M.; Karadogan, S.; Gobom, J.; Furkert, J.; Oksche, A.; Krause, E.; Tran, T.N.; et al. Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 297-302
18. Yang, R.; Smolders, I.; Vanderheyden, P.; Demaegdt, H.; van Eeckhaut, A.; Vauquelin, G.; Lukaszuk, A.; Tourwé, D.; Chai, S.Y.; Albiston, A.L.; et al. Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent. Hypertension 2011, 57, 956-964
19. Habiyakare, B.; Alsaadon, H.; Mathai, M.L.; Hayes, A.; Zulli, A. Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: Differential effects of alamandine and Ang (1-7). Int. J. Exp. Pathol. 2014, 95, 290-295
20. Badejo, A.; Greco, A.J.; Casey, D.B.; Cook, J.L.; Murthy, S.N.; Kadowitz, P.J. Analysis of hemodynamic responses and the proliferative effect of the novel angiotensin peptide Angiotensin A. FASEB J. 2009, 23, 935.2.
21. Coutinho, D.C.; Foureaux, G.; Rodrigues, K.D.; Salles, R.L.; Moraes, P.L.; Murça, T.M.; de Maria, M.L.; Gomes, E.R.; Santos, R.A.; Guatimosim, S.; et al. Cardiovascular effects of angiotensin A: A novel peptide of the renin-angiotensin system. J. Renin Angiotensin Aldosterone Syst. 2014, 15, 480-486
22. Lautner, R.Q.; Villela, D.C.; Fraga-Silva, R.A.; Silva, N.; Verano-Braga, T.; Costa-Fraga, F.; Jankowski, J.; Jankowski, V.; Sousa, F.; Alzamora, A.; et al. Discovery and characterization of alamandine: A novel component of the renin-angiotensin system. Circ. Res. 2013, 112, 1104-1111
23. Le Tran, Y.; Forster, C. Angiotensin-(1-7) and the rat aorta: Modulation by the endothelium. J. Cardiovasc. Pharmacol. 1997, 30, 676-682
24. Villela, D.C.; Passos-Silva, D.G.; Santos, R.A. Alamandine: A new member of the angiotensin family. Curr. Opin. Nephrol. Hypertens. 2014, 23, 130-134
25. Mendoza-Torres, E.; Oyarzún, A.; Mondaca-Ruff, D.; Azocar, A.; Castro, P.F.; Jalil, J.E.; Chiong, M.; Lavandero, S.; Ocaranza, M.P. ACE2 and vasoactive peptides: Novel players in cardiovascular/renal remodeling and hypertension. Ther. Adv. Cardiovasc. Dis. 2015, 9, 217-237
26. Dong, X.; Han, S.; Zylka, M.J.; Simon, M.I.; Anderson, D.J. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 2001, 106, 619-632
27. Lembo, P.M.; Grazzini, E.; Groblewski, T.; O’Donnell, D.; Roy, M.O.; Zhang, J.; Hoffert, C.; Cao, J.; Schmidt, R.; Pelletier, M.; et al. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat. Neurosci. 2002, 5, 201-209
28. Zhang, L.; Taylor, N.; Xie, Y.; Ford, R.; Johnson, J.; Paulsen, J.E.; Bates, B. Cloning and expression of MRG receptors in macaque, mouse, and human. Brain Res. Mol. Brain Res. 2005, 133, 187-197
29. Santos, R.A.; Simoes e Silva, A.C.; Maric, C.; Silva, D.M.; Machado, R.P.; de Buhr, I.; Heringer-Walther, S.; Pinheiro, S.V.; Lopes, M.T.; Bader, M.; et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. USA 2003, 100, 8258-8263
30. Gembardt, F.; Grajewski, S.; Vahl, M.; Schultheiss, H.P.; Walther, T. Angiotensin metabolites can stimulate receptors of the Mas-related genes family. Mol. Cell. Biochem. 2008, 319, 115-123
31. Shinohara, T.; Harada, M.; Ogi, K.; Maruyama, M.; Fujii, R.; Tanaka, H.; Fukusumi, S.; Komatsu, H.; Hosoya, M.; Noguchi, Y.; et al. Identification of a G protein-coupled receptor specifically responsive to β-alanine. J. Biol. Chem. 2004, 279, 23559-23564
32. Crozier, R.A.; Ajit, S.K.; Kaftan, E.J.; Pausch, M.H. MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J. Neurosci. 2007, 27, 4492-4496
33. Etelvino, G.M.; Peluso, A.A.; Santos, R.A. New components of the renin-angiotensin system: Alamandine and the MAS-related G protein-coupled receptor D. Curr. Hypertens. Rep. 2014, 16, 433
34. Avula, L.R.; Buckinx, R.; Favoreel, H.; Cox, E.; Adriaensen, D.; van Nassauw, L.; Timmermans, J.P. Expression and distribution patterns of Mas-related gene receptor subtypes A-H in the mouse intestine: Inflammation-induced changes. Histochem. Cell. Biol. 2013, 139, 639-658
35. Nishimura, S.; Uno, M.; Kaneta, Y.; Fukuchi, K.; Nishigohri, H.; Hasegawa, J.; Komori, H.; Takeda, S.; Enomoto, K.; Nara, F.; et al. MRGD, a MAS-related G-protein coupled receptor, promotes tumorigenisis and is highly expressed in lung cancer. PLoS ONE 2012, 7, e38618
36. Uno, M.; Nishimura, S.; Fukuchi, K.; Kaneta, Y.; Oda, Y.; Komori, H.; Takeda, S.; Haga, T.; Agatsuma, T.; Nara, F.J. Identification of physiologically active substances as novel ligands for MRGPRD. Biomed. Biotechnol. 2012, 2012, 816159
37. Tetzner, A.; Gebolys, K.; Meinert, C.; Klein, S.; Uhlich, A.; Trebicka, J.; Villacañas, Ó.; Walther, T. G-protein-coupled receptor MrgD is a receptor for angiotensin-(1-7) involving adenylyl cyclase, cAMP, and phosphokinase A. Hypertension 2016, 68, 185-194
38. Qu, L.; Fan, N.; Ma, C.; Wang, T.; Han, L.; Fu, K.; Wang, Y.; Shimada, S.G.; Dong, X.; LaMotte, R.H. Enhanced excitability of MRGPRA3- and MRGPRD-positive nociceptors in a model of inflammatory itch and pain. Brain 2014, 137, 1039-1050
39. Liu, Q.; Sikand, P.; Ma, C.; Tang, Z.; Han, L.; Li, Z.; Sun, S.; LaMotte, R.H.; Dong, X. Mechanisms of itch evoked by β-alanine. J. Neurosci. 2012, 32, 14532-14537